1,415 research outputs found

    Fluid machines: Expanding the limits, past and future

    Get PDF
    During the 40 yr period from 1940 to 1980, the capabilities and operating limits of fluid machines were greatly extended. This was due to a research program, carried out to meet the needs of aerospace programs. Some of the events are reviewed. Overall advancements of all machinery components are discussed followed by a detailed examination of technology advancements in axial compressors and pumps. Future technology needs are suggested

    The great outdoors: how a green exercise environment can benefit all

    Get PDF
    The studies of human and environment interactions usually consider the extremes of environment on individuals or how humans affect the environment. It is well known that physical activity improves both physiological and psychological well-being, but further evidence is required to ascertain how different environments influence and shape health. This review considers the declining levels of physical activity, particularly in the Western world, and how the environment may help motivate and facilitate physical activity. It also addresses the additional physiological and mental health benefits that appear to occur when exercise is performed in an outdoor environment. However, people's connectedness to nature appears to be changing and this has important implications as to how humans are now interacting with nature. Barriers exist, and it is important that these are considered when discussing how to make exercise in the outdoors accessible and beneficial for all. The synergistic combination of exercise and exposure to nature and thus the 'great outdoors' could be used as a powerful tool to help fight the growing incidence of both physical inactivity and non-communicable disease. © 2013 Gladwell et al.; licensee BioMed Central Ltd

    Anticoagulants for acute ischaemic stroke

    Get PDF
    Peer reviewedPublisher PD

    Off-design correlation for losses due to part-span dampers on transonic rotors

    Get PDF
    Experimental data from 10 transonic fan rotors were used to correlate losses created by part-span dampers located near the midchord position on the rotor blades. The design tip speed of these rotors varied from 419 to 425 m/sec, and the design pressure ratio varied from 1.6 to 2.0. Additional loss caused by the dampers for operating conditions between 50 and 100 percent of design speed were correlated with relevant aerodynamic and geometric parameters. The resulting correlation predicts the variation of total-pressure-loss coefficient in the damper region to a good approximation

    Creating adaptive and individual personalities in many characters without hand crafting behaviours

    Get PDF
    Believable characters significantly increase the immersion of users or players in interactive applications. A key component of believable characters is their personality, which has previously been implemented statically using the time consuming task of hand-crafting individuality for each character. Often personality has been modeled based on theories that assume behavior is the same regardless of situation and environment. This paper presents a simple affective and cognitive framework for interactive entertainment characters that allows adaptation of behavior based on the environment and emotions. Different personalities are reflected in behavior preferences which are generated based on individual experience. An initial version of the framework has been implemented in a simple scenario to explore which parameters have the greatest effect on agent diversity

    Data summary and computer program for axial-flow pump rotor performance

    Get PDF
    Assembly of noncavitating blade element performance data for axial-flow pump rotor configurations has been collected and organized. Program facilitates handling large amounts of experimental data involved and may be used as data reduction program to process flow and performance measurements from other axial-flow pump configurations

    Using adaptation and goal context to automatically generate individual personalities for virtual characters

    Get PDF
    Personality is a key component of characters that inhabit immersive virtual environments, such as games and virtual agent applications. In order to be distinguishable from other characters in the environment, each character should have its own personality in the form of different observable behaviour, not solely in its physical appearance or animation. Previous work in this field has mostly relied on time-consuming, handcrafted characters and static, trait-based approaches to personality. Our goal is a method to develop complex, individual personalities without handcrafting every behaviour. Unlike most implemented versions of personality theories, cognitive-social theories of personality address how personality is developed and adapts throughout childhood and over our lifetimes. Cognitive-social theories also emphasise the importance of situations in determining how we behave. From this basis, we believe that personality should be individual, adaptive, and based on context. Characters in current state-of-the-art games and virtual environments do not demonstrate all of these features without extensive handcrafting. We propose a model where personality influences both decision-making and evaluation of reward. Characters use their past experiences in the form of simple somatic markers, or gut-instinct, to make decisions; and determine rewards based on their own personal goals, rather than via external feedback. We evaluated the model by implementation of a simple game and tested it using quantitative criteria, including a purpose-designed individuality measure. Results indicate that, although characters are given the same initial personality template, it is possible to develop different personalities (in the form of behaviour) based on their unique experiences in the environment and relationships with other characters. This work shows a way forward for more automated development of personalities that are individual, context-aware and adapt to users and the environment

    An Experimental Scanning Capacitance Microscope

    Get PDF
    A fine needle stylus mounted to a three-dimensional piezo system is scanned across the sample in x-and y-direction, while a constant spacing between tip and sample, i.e., constant tip-to-sample capacitance, is maintained in z-direction. This is accomplished by vibrating the tip in z-direction at 1 kHz by typically 0.1 microns and by detecting the capacitance modulation from the shifting of the resonance of a tuned 1 GHz line. The horizontal resolution achieved so far is limited by the tip radius at about 200 nm and the vertical resolution is about 5 nm. The theoretical limits for finer tips are 7 nm and 1 nm for horizontal and vertical resolution, respectively

    Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation

    Get PDF
    Objectives: To systematically review the effectiveness and cost-effectiveness of palivizumab for the prevention of respiratory syncytial virus (RSV) in children and examine prognostic factors to determine whether subgroups can be identified with important differences in cost-effectiveness. Data sources: Bibliographic databases were searched from inception to March 2007 for literature on the effectiveness and cost-effectiveness of prophylaxis with palivizumab. Review methods: The literature was systematically reviewed and current economic evaluations were analysed to identify which parameters were driving the different cost-effectiveness estimates. A probabilistic decision-analytical model was built to assess the cost-effectiveness of prophylaxis with palivizumab for children at risk of RSV infection and the parameters populated with the best estimates thought most applicable to the UK. We also constructed a new model, the Birmingham Economic Evaluation (BrumEE). Cost-effectiveness analyses were undertaken from both NHS and societal perspectives. Results: Two randomised controlled trials (RCTs) were identified. Prophylaxis with palivizumab for preterm infants without chronic lung disease (CLD) or children with CLD resulted in a 55% reduction in RSV hospital admission: 4.8% (48/1002) in the palivizumab group and 10.6% (53/500) in the no prophylaxis group (p=0.0004). Prophylaxis with palivizumab was associated with a 45% reduction in hospitalisation rate RSV among children with coronary heart disease (CHD). Hospitalisation rates for RSV were 5.3% (34/639) in the palivizumab group and 9.7% (63/648) in the no prophylaxis group (p=0.003). Of existing economic evaluations, 3 systematic reviews and 18 primary studies were identified. All the systematic reviews concluded that the potential costs of palivizumab were far in excess of any potential savings achieved by decreasing hospital admission rates, and that the use of palivizumab was unlikely to be cost-effective in all children for whom it is recommended, but that its continued use for particularly high-risk children may be justified. The incremental cost-effectiveness ratios (ICERs) of the primary studies varied 17-fold for life-years gained (LYG), from £25,800/ LYG to £404,900/LYG, and several hundred-fold for quality-adjusted life years (QALYs), from £3200/QALY to £1,489,700/QALY for preterm infants without CLD or children with CLD. For children with CHD, the ICER varied from £5300/LYG to £7900/LYG and from £7500/ QALY to £68,700/QALY. An analysis of what led to the discrepant ICERs showed that the assumed mortality rate for RSV infection was the most important driver. The results of the BrumEE confirm that palivizumab does not reach conventional levels of cost-effectiveness in any of the licensed indications if used for all eligible children. Conclusions: Prophylaxis with palivizumab is clinically effective for the reducing the risk of serious lower respiratory tract infection caused by RSV infection and requiring hospitalisation in high-risk children, but if used unselectively in the licensed population, the ICER is double that considered to represent good value for money in the UK. The BrumEE shows that prophylaxis with palivizumab may be cost-effective (based on a threshold of £30,000/QALY) for children with CLD when the children have two or more additional risk factors. Future research should initially focus on reviewing systematically the major uncertainties for patient subgroups with CLD and CHD and then on primary research to address the important uncertainties that remain
    corecore